State Street Corp Pro Phase Labs, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, State Street Corp holds 40,163 shares of PRPH stock, worth $167,881. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,163
Previous 40,163
-0.0%
Holding current value
$167,881
Previous $181,000
43.09%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PRPH
# of Institutions
32Shares Held
1.66MCall Options Held
2.4KPut Options Held
1K-
Vanguard Group Inc Valley Forge, PA619KShares$2.59 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny235KShares$981,4890.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL154KShares$642,2520.0% of portfolio
-
Geode Capital Management, LLC Boston, MA138KShares$578,5570.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL85.7KShares$358,2260.31% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $67M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...